Skip to main content
Premium Trial:

Request an Annual Quote

Caprotec, Bayer CropScience Reach Screening Deal

NEW YORK (GenomeWeb News) – Caprotec Bioanalytics has reached an agreement to use its technology to screen an undisclosed new active ingredient from Bayer CropScience.

The deal announced today calls for Berlin-based Caprotec to use its Capture Compound Mass Spectrometry technology to profile interactions of Bayer's ingredient in the relevant biological system. The technology, based on tri-functional molecules called capture compounds, can be used to define and confirm drug targets and discover off-target proteins that cause side effects.

Financial and other details were not disclosed.

In the spring, Caprotec announced it had raised $1.4 million to leverage its CCMS technology into new markets and to execute partnerships with large pharma firms.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.